Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | SAREPTA THERAPEUTICS INC | $11.01B | $1.24B | -$461.21M | -$535.98M | -$5.80 | 33.26% | 32.80% | N/A | N/A | 2024-04-30 | |
| CMRX | CHIMERIX INC | $82.07M | $324.00k | -$82.09M | -$82.10M | -$0.93 | -99.04% | -46.24% | N/A | N/A | 2024-05-02 | |
| IFRX | INFLARX NV | $77.14M | $68.58k | -$45.72M | -$46.38M | -$0.85 | N/A | N/A | N/A | N/A | 2024-05-09 | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $3.03B | $4.01M | -$212.22M | -$214.53M | -$3.69 | -15.28% | 10.57% | N/A | N/A | 2024-05-02 | |
| PRTC | PURETECH HEALTH PLC | $709.79M | $15.62M | -$97.18M | -$50.35M | -$1.80 | -10.18% | 43.86% | N/A | N/A | 2024-04-25 | |
| STTK | SHATTUCK LABS INC | $426.32M | $1.66M | -$82.89M | -$87.30M | -$2.05 | 154.14% | -40.62% | N/A | N/A | 2024-05-07 | |
| MREO | MEREO BIOPHARMA GROUP PLC | $377.29M | $10.00M | -$27.34M | -$29.47M | -$0.20 | N/A | N/A | N/A | N/A | 2024-05-21 | |
| QSI | QUANTUM-SI INC | $232.50M | $1.08M | -$90.40M | -$95.96M | -$0.68 | N/A | N/A | N/A | N/A | 2024-05-09 | |
| IMCR | IMMUNOCORE HOLDINGS PLC | $2.66B | $249.43M | -$50.00M | -$55.29M | -$1.13 | 43.05% | 53.19% | N/A | N/A | 2024-05-08 | |
| IMTX | IMMATICS NV | $878.75M | $58.69M | -$97.57M | -$105.43M | -$1.30 | -67.37% | 69.15% | N/A | N/A | 2024-05-14 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | $947.16M | $314.00k | -$235.32M | -$237.73M | -$5.31 | -82.28% | -48.16% | N/A | N/A | 2024-05-07 | |
| OCS | OCULIS HOLDING AG | $439.80M | $1.00M | -$98.97M | -$100.91M | -$3.38 | 7.19% | N/A | N/A | N/A | ||
| VCYT | VERACYTE INC | $1.42B | $361.05M | -$45.27M | -$74.40M | -$1.02 | 21.76% | 31.45% | N/A | N/A | 2024-05-02 | |
| MOLN | MOLECULAR PARTNERS AG | $128.46M | $8.00M | -$61.83M | -$70.44M | -$2.15 | -95.89% | N/A | N/A | N/A | ||
| LQDA | LIQUIDIA CORP | $1.03B | $17.49M | -$69.65M | -$78.50M | -$1.21 | 9.75% | 45.23% | N/A | N/A | 2024-05-02 | |
| CRBU | CARIBOU BIOSCIENCES INC | $362.16M | $34.48M | -$96.30M | -$102.07M | -$1.38 | 148.91% | N/A | N/A | N/A | 2024-05-07 | |
| BLUE | BLUEBIRD BIO INC | $108.24M | $21.73M | -$95.08M | -$91.17M | -$0.60 | 322.60% | -11.27% | N/A | N/A | 2024-05-07 | |
| ATAI | ATAI LIFE SCIENCES NV | $356.96M | $314.00k | -$35.85M | -$40.22M | -$0.25 | 34.76% | N/A | N/A | N/A | 2024-05-07 | |
| AUPH | AURINIA PHARMACEUTICALS INC | $723.09M | $175.51M | -$63.05M | -$78.02M | -$0.54 | 30.95% | 227.90% | N/A | N/A | 2024-05-02 | |
| GLMD | GALMED PHARMACEUTICALS LTD | $1.79M | $0.00 | -$7.46M | -$6.91M | -$2.50 | N/A | -100.00% | N/A | N/A | 2024-05-30 | |
| YMAB | Y-MABS THERAPEUTICS INC | $662.79M | $84.82M | -$24.94M | -$21.43M | -$0.49 | 29.96% | N/A | N/A | N/A | 2024-05-06 | |
| QNCX | QUINCE THERAPEUTICS INC | $43.09M | $0.00 | -$31.26M | -$31.39M | -$0.84 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| CASI | CASI PHARMACEUTICALS INC | $31.30M | $33.88M | -$22.29M | -$26.96M | -$2.02 | -21.41% | N/A | N/A | N/A | 2024-04-24 | |
| DNTH | DIANTHUS THERAPEUTICS INC | $708.43M | $2.83M | -$43.20M | -$43.56M | -$8.45 | -55.96% | N/A | N/A | N/A | 2024-05-13 | |
| HOTH | HOTH THERAPEUTICS INC | $5.28M | $0.00 | -$7.85M | -$7.85M | -$2.30 | N/A | N/A | N/A | N/A | 2024-05-15 | |
| CYCN | CYCLERION THERAPEUTICS INC | $8.62M | $0.00 | -$5.62M | -$5.26M | -$2.25 | -100.00% | N/A | N/A | N/A | 2024-05-09 | |
| MTEM | MOLECULAR TEMPLATES INC | $8.92M | $57.31M | $1.16M | -$8.12M | $1.80 | 190.10% | 33.96% | -92.71% | N/A | 2024-05-13 | |
| BEAM | BEAM THERAPEUTICS INC | $2.10B | $377.71M | -$111.15M | -$132.53M | -$1.72 | 520.01% | N/A | N/A | N/A | 2024-05-08 | |
| MESO | MESOBLAST LTD | $475.94M | $7.25M | N/A | -$73.06M | -$0.91 | -5.28% | -14.93% | N/A | N/A | 2024-05-30 | |
| ARVN | ARVINAS INC | $2.28B | $78.50M | -$359.70M | -$367.30M | -$6.62 | -40.26% | 40.53% | N/A | N/A | 2024-05-03 | |
| CCCC | C4 THERAPEUTICS INC | $468.54M | $20.76M | -$121.80M | -$132.49M | -$2.67 | -33.25% | 1.40% | N/A | N/A | 2024-05-02 | |
| IKNA | IKENA ONCOLOGY INC | $61.29M | $9.16M | -$65.59M | -$68.17M | -$1.63 | -41.35% | N/A | N/A | N/A | 2024-05-13 | |
| MRNA | MODERNA INC | $39.66B | $6.85B | -$3.32B | -$4.71B | -$12.33 | -64.45% | 119.28% | N/A | N/A | 2024-05-02 | |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC | $7.05M | $9.00k | -$5.19M | -$5.29M | -$3.76 | -89.84% | -40.86% | N/A | N/A | 2024-05-10 | |
| CALT | CALLIDITAS THERAPEUTICS AB | $530.23M | $105.20M | N/A | -$26.74M | -$0.99 | 214.74% | N/A | N/A | N/A | 2024-05-07 | |
| NTLA | INTELLIA THERAPEUTICS INC | $2.10B | $36.28M | -$472.22M | -$481.19M | -$5.42 | -30.40% | 3.57% | N/A | N/A | 2024-05-02 | |
| DNLI | DENALI THERAPEUTICS INC | $2.41B | $330.53M | -$128.47M | -$145.22M | -$1.06 | 204.74% | 20.67% | N/A | N/A | 2024-05-06 | |
| SPRC | SCISPARC LTD | $1.48M | $797.51k | $1.87M | $1.42M | -$4.00 | 108.44% | N/A | N/A | N/A | ||
| QTTB | Q32 BIO INC | $80.71M | $1.16M | -$110.32M | -$112.96M | -$35.10 | -63.97% | -26.32% | N/A | N/A | 2024-05-09 | |
| GLYC | GLYCOMIMETICS INC | $138.57M | $10.00k | -$35.89M | -$36.90M | -$0.58 | -86.67% | N/A | N/A | N/A | 2024-05-01 | |
| IMNM | IMMUNOME INC | $1.10B | $14.02M | -$106.08M | -$106.81M | -$5.38 | N/A | N/A | N/A | N/A | 2024-05-03 | |
| ALLO | ALLOGENE THERAPEUTICS INC | $591.82M | $95.00k | -$313.07M | -$327.27M | -$2.09 | -39.10% | N/A | N/A | N/A | 2024-05-01 | |
| GTHX | G1 THERAPEUTICS INC | $212.97M | $82.51M | -$34.30M | -$47.97M | -$0.93 | 60.84% | N/A | N/A | N/A | 2024-05-01 | |
| INO | INOVIO PHARMACEUTICALS INC | $225.17M | $832.01k | -$130.39M | -$135.12M | -$6.09 | -91.89% | -51.33% | N/A | N/A | 2024-05-08 | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $3.20B | $5.45M | -$321.78M | -$325.10M | -$5.15 | N/A | N/A | N/A | N/A | 2024-05-01 | |
| MIST | MILESTONE PHARMACEUTICALS INC | $93.54M | $1.00M | -$57.04M | -$59.69M | -$1.39 | -80.00% | N/A | N/A | N/A | 2024-05-09 | |
| LYEL | LYELL IMMUNOPHARMA INC | $612.37M | $130.00k | -$214.38M | -$234.63M | -$0.93 | -99.85% | N/A | N/A | N/A | 2024-05-07 | |
| PLUR | PLURI INC | $29.62M | $357.00k | -$21.99M | -$23.95M | -$4.64 | 10.53% | 48.16% | N/A | N/A | 2024-05-08 | |
| KROS | KEROS THERAPEUTICS INC | $2.09B | $151.00k | -$150.63M | -$152.99M | -$5.20 | N/A | -56.77% | N/A | N/A | 2024-05-02 | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $977.81M | $59.61M | -$227.43M | -$262.14M | -$3.78 | 1,517.09% | N/A | N/A | N/A | 2024-05-07 | |
| PGEN | PRECIGEN INC | $338.53M | $6.23M | -$89.23M | -$95.90M | -$0.39 | -76.87% | -47.16% | N/A | N/A | 2024-05-08 | |
| CUE | CUE BIOPHARMA INC | $72.72M | $5.49M | -$46.05M | -$50.73M | -$1.11 | 340.96% | 36.88% | N/A | N/A | 2024-05-07 | |
| MRNS | MARINUS PHARMACEUTICALS INC | $65.57M | $30.99M | -$125.31M | -$141.41M | -$2.63 | 21.63% | N/A | N/A | N/A | 2024-05-09 | |
| ABCL | ABCELLERA BIOLOGICS INC | $1.19B | $38.03M | -$143.14M | -$146.40M | -$0.51 | -92.17% | 33.91% | N/A | N/A | 2024-05-02 | |
| XOMA | XOMA CORP | $283.44M | $4.76M | -$39.24M | -$46.30M | -$4.04 | -21.06% | -2.13% | N/A | N/A | 2024-05-07 | |
| COCP | COCRYSTAL PHARMA INC | $14.85M | $0.00 | -$17.16M | -$17.98M | -$1.87 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| INVA | INNOVIVA INC | $914.90M | $310.46M | $248.96M | $179.72M | $2.75 | -6.30% | 3.53% | -10.42% | -6.84% | 2024-05-07 | |
| CVKD | CADRENAL THERAPEUTICS INC | $6.24M | $0.00 | -$8.34M | -$8.36M | -$0.62 | N/A | N/A | N/A | N/A | ||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $3.01M | $253.57k | -$1.38M | -$3.92M | -$0.99 | -50.40% | N/A | N/A | N/A | ||
| OVID | OVID THERAPEUTICS INC | $224.15M | $391.70k | -$50.74M | -$52.34M | -$0.74 | -73.93% | N/A | N/A | N/A | 2024-05-03 | |
| LXRX | LEXICON PHARMACEUTICALS INC | $417.37M | $1.20M | -$163.46M | -$177.12M | -$0.80 | 766.19% | -54.71% | N/A | N/A | 2024-04-30 | |
| LUMO | LUMOS PHARMA INC | $20.43M | $2.05M | -$34.02M | -$34.03M | -$4.18 | 34.67% | -30.31% | N/A | N/A | 2024-05-01 | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $4.23B | $58.88M | -$31.41M | -$32.18M | -$0.64 | 95.84% | 142.30% | N/A | N/A | 2024-05-09 | |
| MGNX | MACROGENICS INC | $1.04B | $58.75M | $5.51M | -$9.06M | -$0.15 | -61.33% | -0.46% | N/A | N/A | 2024-05-07 | |
| CDIO | CARDIO DIAGNOSTICS HOLDINGS INC | $22.24M | $17.07k | -$1.53M | -$8.38M | -$0.66 | 1,696.32% | N/A | N/A | N/A | ||
| APRE | APREA THERAPEUTICS INC | $31.77M | $583.23k | -$15.50M | -$14.29M | -$3.95 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| SLRN | ACELYRIN INC | $505.60M | $0.00 | -$381.37M | -$381.64M | -$5.43 | N/A | N/A | N/A | N/A | ||
| LYRA | LYRA THERAPEUTICS INC | $322.61M | $1.56M | -$62.34M | -$62.68M | -$1.26 | 14.31% | 4.60% | N/A | N/A | 2024-05-10 | |
| ABSI | ABSCI CORP | $606.78M | $5.72M | -$95.46M | -$110.57M | -$1.20 | -0.50% | N/A | N/A | N/A | 2024-05-13 | |
| VIR | VIR BIOTECHNOLOGY INC | $1.13B | $86.18M | -$601.03M | -$615.06M | -$4.59 | -94.67% | 51.87% | N/A | N/A | 2024-05-02 | |
| PALI | PALISADE BIO INC | $5.05M | $250.00k | -$12.20M | -$12.32M | -$27.00 | N/A | -0.78% | N/A | N/A | 2024-05-10 | |
| KRRO | KORRO BIO INC | $588.57M | $0.00 | -$73.91M | -$81.17M | -$53.08 | N/A | N/A | N/A | N/A | 2024-05-10 | |
| KYMR | KYMERA THERAPEUTICS INC | $2.07B | $78.59M | -$143.20M | -$146.96M | -$2.52 | 67.84% | N/A | N/A | N/A | 2024-05-02 | |
| NGNE | NEUROGENE INC | $452.43M | $0.00 | -$32.35M | -$36.32M | $27.76 | N/A | -100.00% | N/A | N/A | 2024-05-06 | |
| ALEC | ALECTOR INC | $508.43M | $97.06M | -$116.33M | -$130.39M | -$1.56 | -27.36% | 28.52% | N/A | N/A | 2024-05-02 | |
| CRDF | CARDIFF ONCOLOGY INC | $205.07M | $488.00k | -$41.04M | -$41.47M | -$0.93 | 26.42% | 5.22% | N/A | N/A | 2024-05-02 | |
| RLAY | RELAY THERAPEUTICS INC | $884.15M | $25.55M | -$336.70M | -$341.97M | -$2.79 | 1,749.82% | N/A | N/A | N/A | 2024-05-02 | |
| IOBT | IO BIOTECH INC | $99.48M | $0.00 | -$84.48M | -$86.08M | -$1.98 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| CLDX | CELLDEX THERAPEUTICS INC | $2.16B | $6.88M | -$138.42M | -$141.43M | -$2.92 | 192.02% | -6.32% | N/A | N/A | 2024-05-02 | |
| LSTA | LISATA THERAPEUTICS INC | $23.59M | $0.00 | -$22.98M | -$20.84M | -$2.58 | N/A | N/A | N/A | N/A | 2024-05-07 | |
| SVRA | SAVARA INC | $712.84M | $0.00 | -$50.09M | -$54.70M | -$0.33 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| AVXL | ANAVEX LIFE SCIENCES CORP | $338.30M | $0.00 | -$43.04M | -$43.16M | -$0.55 | N/A | N/A | N/A | N/A | 2024-05-07 | |
| ELVN | ENLIVEN THERAPEUTICS INC | $772.79M | $0.00 | -$70.98M | -$71.58M | -$2.01 | N/A | N/A | N/A | N/A | 2024-05-09 | |
| VCEL | VERICEL CORP | $2.29B | $197.52M | $8.93M | -$3.18M | -$0.07 | 20.17% | 16.80% | N/A | N/A | 2024-05-08 | |
| VRNA | VERONA PHARMA PLC | $1.31B | $0.00 | -$51.16M | -$54.37M | -$0.72 | -100.00% | N/A | N/A | N/A | 2024-05-07 | |
| HOWL | WEREWOLF THERAPEUTICS INC | $239.76M | $19.94M | -$30.89M | -$37.37M | -$1.05 | 21.60% | N/A | N/A | N/A | 2024-05-08 | |
| DTIL | PRECISION BIOSCIENCES INC | $89.01M | $48.73M | -$50.83M | -$61.32M | -$15.96 | 94.15% | 34.96% | N/A | N/A | 2024-05-07 | |
| TERN | TERNS PHARMACEUTICALS INC | $301.92M | $0.00 | -$89.09M | -$90.21M | -$1.27 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| ATOS | ATOSSA THERAPEUTICS INC | $192.97M | $0.00 | -$30.07M | -$30.09M | -$0.24 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| TVTX | TRAVERE THERAPEUTICS INC | $468.01M | $145.24M | -$61.31M | -$111.40M | -$1.50 | 32.69% | -2.43% | N/A | N/A | 2024-05-02 | |
| ETNB | 89BIO INC | $876.11M | $0.00 | -$133.26M | -$142.19M | -$2.00 | N/A | N/A | N/A | N/A | 2024-05-02 | |
| ATXS | ASTRIA THERAPEUTICS INC | $609.42M | $0.00 | -$72.89M | -$72.89M | -$2.42 | N/A | N/A | N/A | N/A | 2024-05-09 | |
| PMCB | PHARMACYTE BIOTECH INC | $18.20M | $0.00 | -$1.14M | -$11.51M | -$1.20 | N/A | N/A | N/A | N/A | ||
| EVGN | EVOGENE LTD | $35.41M | $5.64M | -$20.34M | -$23.88M | -$0.52 | 236.72% | 26.41% | N/A | N/A | 2024-05-07 | |
| AKRO | AKERO THERAPEUTICS INC | $1.23B | $0.00 | -$148.40M | -$151.76M | -$2.89 | N/A | N/A | N/A | N/A | 2024-05-13 | |
| TBPH | THERAVANCE BIOPHARMA INC | $466.72M | $57.42M | -$40.77M | -$55.19M | -$1.00 | 11.84% | -1.00% | N/A | N/A | 2024-05-06 | |
| TRVI | TREVI THERAPEUTICS INC | $183.78M | $0.00 | -$28.58M | -$29.07M | -$0.29 | N/A | N/A | N/A | N/A | 2024-05-09 | |
| CABA | CABALETTA BIO INC | $785.86M | $0.00 | -$64.18M | -$67.68M | -$1.65 | N/A | N/A | N/A | N/A | 2024-05-09 | |
| TCRX | TSCAN THERAPEUTICS INC | $341.40M | $21.05M | -$80.10M | -$89.22M | -$1.36 | 55.52% | N/A | N/A | N/A | 2024-05-07 | |
| LRMR | LARIMAR THERAPEUTICS INC | $461.91M | $0.00 | -$36.64M | -$36.95M | -$0.84 | N/A | N/A | N/A | N/A | 2024-05-13 |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.